These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33923873)

  • 1. Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus.
    Park SS; Rodriguez Ortega R; Agudelo CW; Perez Perez J; Perez Gandara B; Garcia-Arcos I; McCarthy C; Geraghty P
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33923873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1 antitrypsin: A novel biomarker and potential therapeutic approach for metabolic diseases.
    Zhang X; Ostrov DA; Tian H
    Clin Chim Acta; 2022 Sep; 534():71-76. PubMed ID: 35810800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation therapy with alpha1-antitrypsin: novel perspectives.
    Sabina J; Tobias W
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):90-8. PubMed ID: 23987997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the clinical indications for α(1)-antitrypsin therapy.
    Lewis EC
    Mol Med; 2012 Sep; 18(1):957-70. PubMed ID: 22634722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).
    Lior Y; Geyra A; Lewis EC
    Expert Opin Ther Pat; 2016 May; 26(5):581-9. PubMed ID: 26966859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An association between Type 2 diabetes and alpha-antitrypsin deficiency.
    Sandström CS; Ohlsson B; Melander O; Westin U; Mahadeva R; Janciauskiene S
    Diabet Med; 2008 Nov; 25(11):1370-3. PubMed ID: 19046232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of alpha-1 antitrypsin in human health and disease.
    de Serres F; Blanco I
    J Intern Med; 2014 Oct; 276(4):311-35. PubMed ID: 24661570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Analysis of Alpha-1-Antitrypsin Functions in Autoimmune Disease Models.
    Song S; Lu Y; Elshikha AS
    Methods Mol Biol; 2018; 1826():143-155. PubMed ID: 30194599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
    Tirado-Conde G; Lara B; Miravitlles M
    Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.
    Campos MA; Geraghty P; Holt G; Mendes E; Newby PR; Ma S; Luna-Diaz LV; Turino GM; Stockley RA
    Am J Respir Crit Care Med; 2019 Aug; 200(3):318-326. PubMed ID: 30965011
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
    Tonelli AR; Brantly ML
    Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation therapy for alpha(1)-antitrypsin deficiency.
    Juvelekian GS; Stoller JK
    Drugs; 2004; 64(16):1743-56. PubMed ID: 15301559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of alpha-1 antitrypsin in human disease.
    Kim M; Cai Q; Oh Y
    Ann Pediatr Endocrinol Metab; 2018 Sep; 23(3):131-135. PubMed ID: 30286568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
    Mordwinkin NM; Louie SG
    Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
    Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 Antitrypsin Substitution for Extrapulmonary Conditions in Alpha-1 Antitrypsin Deficient Patients.
    Baranovski BM; Schuster R; Nisim O; Brami I; Lior Y; Lewis EC
    Chronic Obstr Pulm Dis; 2018 Sep; 5(4):267-276. PubMed ID: 30723784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.